The In The Know – Let's Talk ARIKAYCE Program

The In The Know – Let's Talk ARIKAYCE Program is a live discussion designed for people who want to learn more about ARIKAYCE. ARIKAYCE is the first and only FDA-approved treatment option designed specifically for MAC lung disease as part of a multidrug regimen in adults who continue to test positive after at least 6 months of a multidrug regimen alone.